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Introduction
More than half of the world’s population lives in places endemic for soil-transmitted helminths
(STHs), and an estimated 1.45 billion people are infected [1,2]. In 2017, the global burden of
STH infection (Ascaris lumbricoides, hookworm, and Trichuris trichiura) was estimated at 1.9
million disability-adjusted life years (DALYs) [3]. Moderate and heavy infection intensity and
chronic STH infection are associated with anemia, malnutrition, educational loss, and cogni-
tive deficits, but recent systematic reviews and meta-analyses produced conflicting results on
the impact of preventive chemotherapy (PC) [4–6].
The Soil-Transmitted Helminthiasis Advisory Committee (hereafter called “the Commit-
tee”) is a group of independent experts with a broad range of expertise. It is convened annually
by Children Without Worms (CWW), an organization whose purpose is to utilize available
evidence to identify best practices and opportunities for the prevention and control of STH
infection [7]. On November 1 and 2, 2017, the Committee met in Baltimore, Maryland, United
States of America, in order to discuss the critical need to develop a data-driven guide to the
STH endgame on late-stage program functioning, processes, and surveillance. The focus was
on research and field experiences from countries approaching the “elimination of STH infec-
tion as a public health problem” after consecutive years of PC and countries that are now con-
sidering scaling down their PC frequency but may be concerned about infection rebound.
Emphasis was placed on interim recommendations for monitoring and decision-making for
national program managers desiring to achieve the World Health Organization (WHO) goal
of eliminating STH infection as a public health problem by 2020, particularly related to STH
infections in risk groups other than school-age children (SAC), namely preschool-age children
(PSAC) and women of reproductive age (WRA) [8]. The following is the Committee’s recom-
mendations stemming from the Baltimore meeting in November 2017. It complements and
updates the publication derived by the Committee’s meeting a year earlier in Basel, Switzerland
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[7], and was instrumental in shaping the agenda for the October 2018 meeting, convened
jointly by CWW and WHO, with recommendations to be reported elsewhere.
The 2020 roadmap and beyond
In its roadmap for implementation for 2020, WHO set a goal to achieve at least 75% coverage
of PC—either annual or biannual—of SAC and PSAC [9–11]. As we approach 2020, it is
imperative that we not only accelerate what has worked for the control of STH infection–
related morbidity but that we look beyond 2020 and better understand what more is required
to eliminate STH infection as a public health problem.
Fig 1 summarizes progress made in terms of both coverage and impact using 2016 country
data. Despite considerable gains in SAC coverage, less than half of the at-risk countries are
treating PSAC, a number that has not changed much in recent years, yielding a total coverage
level of approximately 50% but with considerable variability of coverage from year to year and
across countries (Fig 2). If the current trend in PC coverage persists, PSAC and the combined
group of children aged 1–14 years will not reach the goal by 2020. Accelerating PSAC PC cov-
erage might avoid that failure, and hence, needs a clear, strong global policy now. While the
initial focus on SAC coverage has enabled the mobilization of resources, other priorities have
emerged, both in places and populations in which the target was not achieved and within areas
that are now shifting priority from scaling up PC to eliminating STH infection as a public
health problem—defined by the WHO as when less than 1% of the at-risk population has mod-
erate or heavy infection (MHI) [8]—and potentially interrupting the transmission of STH
infection [12]. WHO recommends stopping PC once less than 1% of the at-risk population has
MHI infections. Surveillance will, however, need to continue in order to pick up potential
recurrence of infection and to plan further intervention, if warranted. Hence, as we turn our
sights towards and beyond 2020, the Committee recognized it as timely to review and assess
the successes and challenges of progress made to date. Indeed, it is hoped that the Baltimore
2017 meeting deliberations will inform future control strategies and targets.
There have been many important developments by the time the Committee convened in
November 2017, but six are particularly noteworthy:
• updated PC guidelines published by WHO for all at-risk populations [13];
• the Bellagio Declaration focusing on girls and WRA [14];
• widening of WHO’s engagement with experts around the globe [15];
• success of the Global Program to Eliminate Lymphatic Filariasis (GPELF) [16];
• increasing importance for deworming programs to measure impact [17]; and
• the launch by WHO-AFRO of the Expanded Special Project on the Elimination of Neglected
Tropical Diseases (ESPEN) portal (http://espen.afro.who.int), which provides—for the first
time—subnational data on disease endemicity and PC coverage for each of the five
PC-NTDs, including STH infection.
In this Policy Platform, we lay out critical challenges in seven key areas that need attention,
discuss progress until November 2017, and put forward recommendations for immediate
action. Our recommendations arose at a critical juncture for STH control efforts, as current
global policies, goals, and related strategies and resources are revitalized through 2020, a year
which is upon us.
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Fig 1. Progress for PC coverage (by country) in SAC and where STH infection is no longer considered a public health problem (MHI<1%).
Source: 2016 PC data from WHO. � Country with detailed epidemiologic information available. MHI, moderate or heavy infection; PC, preventive
chemotherapy; SAC, school-age children; STH, soil-transmitted helminth.
https://doi.org/10.1371/journal.pntd.0007201.g001
Fig 2. Global PSAC treatment and coverage, 2006–2016. Source: WHO PC Databank, PSAC PC coverage data from 2006–2016; http://www.who.int/
neglected_diseases/preventive_chemotherapy/lf/en/. � Coverage is calculated by dividing the number of children requiring PC and treated by the total
number of children in need of PC. PC, preventive chemotherapy; PSAC, preschool children; WHO, World Health Organization.
https://doi.org/10.1371/journal.pntd.0007201.g002
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Challenges and recommendations
Challenge #1: Incomplete and inconsistent monitoring of program impact
Recommendation: Define standard impact goals and targets post-2020. To date, pro-
grams mainly focused on reporting on PC coverage, as guided by a simplified coverage target
specified by the Roadmap; yet there are few standardized data on program impact. It is note-
worthy that country programs are increasingly interested in quantifying the impact of
deworming on health outcomes [17–19]. Current approaches to measuring impact vary across
countries and across deworming program implementers, limiting comparability and the possi-
bility to appreciate changes over time and across countries and regions. Moreover, impact data
are not readily available, with most of the evaluations conducted by research groups. For the
Africa region, there has been recent progress in data sharing and transparency for neglected
tropical diseases (NTDs), through the work of ESPEN and their data portal [20]. Currently,
there is availability of data on endemicity and coverage at the subnational level for the five
PC-NTDs, including STH infection, for 47 of 49 countries in the AFRO region. This successful
approach to reporting sub-national data should be expanded to the other WHO regions where
STHs are endemic.
The ESPEN portal is starting to include impact assessment data for lymphatic filariasis
and onchocerciasis and there is an opportunity to include comparable data for STH infec-
tion. However, this will require a standardized and comprehensive monitoring and evalua-
tion (M&E) framework that is tied to clearly defined, quantitative goals. For example,
globally, a reported 69.5% of SAC and 50.8% of PSAC requiring PC reportedly received PC
in 2016 [21]. It is conceivable that the observed scale-up of PC targeting STH over the past
decade was a major contributor to the decline in the global burden of STH infection [22–
25]; yet the precise extent to which this coverage has reduced prevalence, intensity, and
burden of STH infection is not known. Country programs, in particular, require a compre-
hensive, standardized, yet flexible approach to measure progress toward morbidity-related
goals. Such an approach would capture essential programmatic elements, and be used by
each country to map their needs, commitment, and resources. This will generate realistic
timelines and planning processes as well as alerting WHO, partners, and donors to better
assess the resource and technical capacity needs of each program. Subnational data with
standardized indicators for anthelmintic drug availability and coverage of the target popula-
tions are critical to track progress at the subnational level where PC program implementa-
tion may not be uniform. Data can also be disaggregated (e.g., by district, sex, and age
categories, and any other useful determinant) to better understand the equity of program
access and delivery for the three target risk groups (i.e., PSAC, SAC, and WRA). PC needs
for refugees and migrants are also increasingly being recognized, and hence, WHO is con-
sidering to add these populations to the at-risk groups, while some countries (especially
those in AFRO and EMRO regions) are actively engaged in estimating access, burden, and
resource issues for migrants.
Challenge #2: Reaching at-risk groups other than SAC
Recommendation: Identify new PC strategies, platforms, and reporting mechanisms.
Deworming of SAC has been shown to reduce disease burden, especially reducing high-bur-
den infections in a cost-effective manner, but the empirical evidence from both multiyear
deworming programs and modeling studies suggest that targeting SAC alone for PC is insuffi-
cient for sustained control and elimination of STH infection [17,26,27]. In particular, this is
the case for T. trichiura due to poor drug efficacy [28,29] and for hookworm due to the age
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distribution of infection. Indeed, in many settings, adults are at particularly high risk of hook-
worm infection and thus contribute substantially to transmission [30]. These issues are in con-
trast to countries where school-based deworming has been coupled with community-based
programs in both experimental studies and as part of lymphatic filariasis control programs
that target entire communities [31]. Using an exclusive school-based intervention platform
potentially excludes 12.8% SAC who are out of school, with some countries like South Sudan
having 66% of their SAC out of school [32]. With that and the availability of a pediatric meben-
dazole preparation as a donation for PSAC, out-of-school children and PSAC can be immedi-
ately prioritized to help achieve the overall children’s coverage goal. Recent progress has been
made on a more comprehensive preventive approach to include all risk groups, as demon-
strated by the Kenya “Breaking Transmission Strategy” in addition to community-wide PC
coverage through the lymphatic filariasis elimination program through USAID. Successful PC
interventions targeting SAC by most countries are generating requests for specific guidance on
the next operational phase: how to efficiently implement sentinel surveillance and which indi-
cators to measure in order to predict, detect, and treat widely dispersed and persistent pockets
of transmission. There is a need to consider how to scale up approaches to reach PSAC, given
the current drug availability and added cost of this approach. Consistent with these needs is a
recognized gap in our current knowledge of disease transmission at low prevalence and persis-
tent environmental factors that facilitate transmission. Thus, there is a renewed need to clearly
identify research gaps and questions that would facilitate implementation in these settings.
A recent report has provided guidance and recommendations for WRA [33]. Building on
this report, WHO needs to develop implementation guidelines linked to clearly defined tar-
gets, both for WRA and PSAC as critical populations at risk of high STH burden [7,14]. Opera-
tional research is also needed to define platforms, partners, and recording and reporting tools
to monitor progress of control programs targeting PSAC and WRA. In addition, there remains
the challenge of providing additional anthelmintic drugs necessary to treat WRA (not targeted
by the current donations). There is optimism that there will be the possible donation of chew-
able Vermox from Johnson & Johnson (J&J) for PSAC, but the quantities donated may not be
enough to cover the total numbers at risk. Consideration of new drug options for WRA needs
immediate discussion at national, regional, and global fora. Data from the GPELF and other
community-based PC programs may provide insight into efficacy and safety issues through
birth cohort studies.
Challenge #3: The risk of anthelmintic drug resistance
Recommendation: Develop standardized indicators to detect emerging resistance.
Experience from the veterinary sector demonstrated that anthelmintic drug resistance devel-
oped after years of large-scale monotherapy [34]. We suspect that if we wait until resistance
is clinically detected in humans, it will be too late to respond [35]. While progress is being
made, there are currently no routine, field-applicable diagnostics that can effectively identify
and monitor signs of emerging resistance, so research on developing such tests urgently
needs financial support. Indeed, we need to better identify resistant genes and to track refu-
gia (i.e., that proportion of the worm population that remains susceptible to anthelmintic
drugs). Human populations with a long history of single-drug deworming that have low
worm burdens but have not reached transmission break points are likely to be at the greatest
risk for the development of drug-resistant parasites. For diagnostic approaches such as quan-
titative polymerase chain reaction (qPCR) to be used in an STH-programmatic setting, we
need to take molecular diagnostics to a level at which we can use its full potential by stan-
dardizing analysis and reporting and including appropriate quality control measures [36]. A
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standardized approach to the monitoring of potential emerging resistance needs to be estab-
lished, especially in those countries that have mature PC programs (e.g., Mexico and Togo,
among others), to track both drug efficacy and mutations known to be associated with resis-
tance [37].
Challenge #4: Poor diagnostics to assess program needs by implementation
stage
Recommendation: Employ validated program stage-specific diagnostic techniques.
There is a need for new diagnostics that are appropriate for informing key decision points for
national STH control programs [38,39]. The Kato–Katz technique, while relatively inexpen-
sive, widely used, and sensitive in detecting MHI, will have lower positive predictive values in
low-prevalence (and low-intensity) settings [40,41]. In addition, some preliminary analysis
from microscopy and PCR has suggested that hookworm infection may be misidentified. New
diagnostic tests have been validated [7], yet there is a need for novel, highly sensitive tests that
can be employed in settings that move from STH control to elimination. However, their spe-
cific role and use in the context of national program implementation needs to be assessed [41].
Furthermore, capacity strengthening for national programs will be needed to fully take advan-
tage of any new diagnostics. Field and laboratory protocols need to be standardized, reference
laboratories established, and training developed for different contexts and languages. Gaps in
the current diagnostic landscape have been identified, and formative research is underway.
The next steps are to finalize and disseminate results and to identify additional resources for
gap areas (e.g., sustaining animal models, conducting field studies to calculate test perfor-
mance in various settings, etc.). Guidelines will then need to be developed to inform country
programs on how to incorporate these tests for improved assessment of program impact and
further planning.
Challenge #5: Limited efficacy of current drugs and gaps in drug
availability
Recommendation: Promote research into combination therapies and fast track pre-
qualification processes. The existing anthelmintic drugs have variable efficacies against dif-
ferent STH species, with particularly low efficacies against T. trichiura when using single-dose
treatments [29]. New efforts must be undertaken to identify and provide guidelines for use
cases for combination therapies in general and specifically in which T. trichiura is the predom-
inant species [42]. In 2018, the WHO Essential Medicines Committee approved the inclusion
of ivermectin for both STH and Strongyloides stercoralis to the WHO Model List of Essential
Medicines [43]. However, there are implications and potential challenges in adding ivermectin
to albendazole and mebendazole in STH deworming programs. Merck provides ivermectin
dedicated for the control of lymphatic filariasis and onchocerciasis, and new manufacturers
will need to become prequalified to meet the growing demand from STH control programs.
Additionally, bioequivalence studies and other considerations will be needed to make the drug
available at low cost. This will take time and requires innovative financing mechanisms.
Challenge #6: Limited coordination with the water, sanitation, and hygiene
(WASH) sector
Recommendation: Identify WASH indicator(s) to be included in routine STH M&E.
As articulated in an editorial put forth in The Lancet [44], the 2020 WHO roadmap identified
the critical role of WASH in the control of STH infection but did not set actionable targets or
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strategies [11]. The STH community has largely avoided establishing an approach for address-
ing WASH or establishing a structure for engagement with the WASH sector. However, the
recent development of the WASH–NTD joint strategy provides an entry point and guidance
for improved communication, coordination, and collaboration [45]. Ample observational evi-
dence [46,47], some recent randomized trials, biological plausibility, and history suggest that
improved WASH is critical in the control and elimination of STH infection. Alignment with
the WASH sector, specifically including WASH indicators as part of STH M&E [48] (and vice
versa) by using data to advocate for WASH activities in STH-endemic areas, employing pro-
gram monitoring, and conducting operational research and advocacy to ensure normative
inclusion of STH-related WASH behaviors (e.g., shoe-wearing [49]), would be valuable contri-
butions in STH control programming. Better quantification of the specific mechanisms and
use of consistent indicators across programs would provide support to the WASH sector on
gaps in typical WASH programming (e.g., type of water sources or food hygiene).
Challenge #7: New targets needed for post-2020
Recommendation: Develop clearly defined, quantitative program targets for all at-risk
groups and move beyond PC coverage estimates. One of the most important next steps as
we move toward 2020 and beyond is the need to establish clearly defined, quantitative program
goals and targets post-2020. The current targets of achieving at least 75% coverage for deworm-
ing for SAC (and PSAC) is in reach, but we know that even meeting this target is insufficient to
achieve elimination of STH as a public health problem. We must also critically evaluate whether
the threshold of 1% prevalence of MHI is useful for M&E of STH morbidity control and mov-
ing toward elimination. There is a need to look beyond simple PC coverage measures and
include impact targets for PSAC and WRA, benchmarks for WASH that will encourage invest-
ment in WASH in STH-endemic areas, and estimates of PC uptake along the distribution
chain that would give accurate estimates for not only availability of the drug, but population
compliance. Addressing Challenges 1–6, articulated above, will support this critical effort.
Outlook
There has been substantial progress in increasing coverage of PC for the control of STH infec-
tion, particularly among SAC and, to a lesser extent, among PSAC. As we approach 2020,
work remains to accelerate action to achieve these targets in many places. At the same time, we
need to think critically about what is needed beyond the 2020 roadmap and increase efforts in
the seven areas discussed in this Policy Platform. This needs to be achieved through active col-
laboration and coordination by pertinent government ministries, researchers, donors, WHO,
drug manufacturers, and multisectoral collaboration [50]. In doing so, it will help ensure prog-
ress toward eliminating STH infection—and other NTDs—as a public health problem, and it
will yield more efficient allocation of resources and greater sustained impact, driven by targets
and thresholds based on scientific evidence.
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